Dr. Hiroto Inaba, MD
- Publications
- 191
- Clinical trials
- 4
- Industry payments
- $68,557
- Medical group
- 1
- Insurance carriers
- 7
- Practice address
- 262 Danny Thomas Place, Memphis, TN 38105
- Practice phone
- Call (901) 495-3300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Inaba's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Hiroto Inaba is a pediatric hematology and oncology physician in Memphis, Tennessee
Dr. Inaba practices at St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital.
Dr. Inaba's NPI, 1356533046, was assigned on August 16, 2007. Dr. Inaba graduated from Other in 1991. Dr. Inaba holds Tennessee license 38058.
- NPI
- 1356533046NPI Registry (opens in a new tab)
- NPI enumeration date
- August 16, 2007
- NPI status
- Active
- Practice phone
- (901) 495-3300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Hiroto Inaba practices at St. Jude Children's Research Hospital in Memphis, Tennessee
Dr. Inaba's primary practice is St. Jude Children's Research Hospital, at 262 Danny Thomas Place, Memphis, TN 38105 in Shelby County. The practice phone is (901) 495-3300.
- St. Jude Children's Research Hospital262 Danny Thomas Place, Memphis, TN 38105 · Shelby CountyPhone(901) 495-3300
Source: Dmand AI Affiliation Data
Dr. Hiroto Inaba is affiliated with 1 medical group
Dr. Inaba's primary practice is St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital. The medical group on file is St. Jude Children's Research Hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Hiroto Inaba's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inaba practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| St. Jude Children's Research Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across St. Jude Childrens Research Hospital and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Hiroto Inaba is one of 141 pediatric hematologys and oncology physicians in Tennessee
Pediatric hematology-oncology is Dr. Inaba's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Inaba is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Inaba's licenses on file in 2 states: Tennessee and Michigan.
Specialties and state licenses
- Pediatric hematology and oncology, TennesseePrimary
- Michigan license
Pediatric hematologys and oncology physicians near Dr. Inaba
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Hiroto Inaba's patients have a median age of 11
Across all payers, Dmand AI patient panel data puts Dr. Inaba's median patient age at 11, with 39% women.
Dr. Inaba's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 11
Patient panel by sex, all payers
- Women39%
- Men61%
Source: Dmand AI Patient Panel Data
Dr. Hiroto Inaba has 191 publications on record
Dmand AI links 191 papers to Dr. Inaba, published from 2006 to 2025. 2024 was the busiest year, with 15. The most frequent topics are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols and Leukemia, Myeloid, Acute. Dr. Inaba has published most often in Cancer. Dr. Inaba's most frequent co-authors are Ching-Hon Pui, MD, Jeffrey E. Rubnitz, MD and Seth Evan Karol, MD.
Dr. Inaba's papers by year, 2016 to 2025
Topics Dr. Inaba writes about most
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Antineoplastic Combined Chemotherapy Protocols
- Leukemia, Myeloid, Acute
- Antineoplastic Agents
- Neoplasm, Residual
- Asparaginase
- Hematopoietic Stem Cell Transplantation
- Cytarabine
Dr. Inaba's most frequent co-authors
- Ching-Hon Pui, MD115 shared papers
- Jeffrey E. Rubnitz, MD63 shared papers
- Seth Evan Karol, MD32 shared papers
Recent publications by Dr. Inaba
See who Dr. Inaba researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Inaba works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Hiroto Inaba has worked on 4 clinical trials
Dmand AI links Dr. Inaba to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Lymphoid and Leukemia. St. Jude Children's Research Hospital sponsors the most, 3.
Clinical trials with Dr. Inaba by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Inaba's trials
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Leukemia, Lymphoid
- Leukemia
- Leukemia, Promyelocytic, Acute
- Disease Attributes
Investigators on the most trials with Dr. Inaba
- Norman James Lacayo, MD2 shared trials
- Jessica A. Bell, MD1 shared trial
- Erin Haag Breese, MD1 shared trial
Recent clinical trials with Dr. Inaba
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma (opens in a new tab)
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma (opens in a new tab)
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies (opens in a new tab)
Expanded Access Program for Revumenib (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Hiroto Inaba received $68,557 in industry payments from 2016 to 2025
CMS Open Payments shows 42 general payments to Dr. Inaba from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Amgen Inc. paid the most, $30,918.
General payments to Dr. Inaba by program year, 2016 to 2025
General payments to Dr. Inaba by kind, 2016 to 2025
- Consulting fees$48,34471%
- Speaker and faculty fees$17,89626%
- Food and beverage$1,1372%
- Honoraria$8801%
- Travel and lodging$3010%
Companies that paid Dr. Inaba the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Hiroto Inaba graduated from Other
Dr. Inaba graduated from Other in 1991.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Hiroto Inaba accepts plans from 7 insurance carriers
Dr. Inaba is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicaid plans come from the most carriers, 4. Check the plan with the practice before a visit.
- Elevance
- Blue Cross Blue Shield of Michigan
- United Healthcare
- AR State Medicaid
- GA State Medicaid
- KY State Medicaid
- NC State Medicaid
Plan types Dr. Inaba accepts, by number of carriers
- Medicaid4
- HMO3
- POS3
- Medicare2
- PPO2
- EPO1
Source: Dmand AI Insurance Network Data
Sources for Dr. Hiroto Inaba's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Hiroto Inaba
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Hiroto Inaba's NPI number?
Dr. Hiroto Inaba's NPI number is 1356533046. It was assigned on August 16, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Hiroto Inaba?
Dr. Hiroto Inaba is a pediatric hematology and oncology physician in Memphis, Tennessee. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Hiroto Inaba practice?
Dr. Inaba practices at 262 Danny Thomas Place, Memphis, TN 38105. Dr. Inaba's primary practice is St. Jude Children's Research Hospital in Memphis, Tennessee, part of St. Jude Childrens Research Hospital.
What is Dr. Hiroto Inaba's office phone number?
The practice phone on file for Dr. Inaba is (901) 495-3300.
What is Dr. Hiroto Inaba's medical license number?
Dr. Inaba holds Tennessee license 38058, one of the licenses on file in 2 states.
Which states has Dr. Hiroto Inaba been licensed in?
Dmand AI has state licenses on file for Dr. Inaba in Tennessee (2003 to 2026) and Michigan (2000 to 2003).
Which hospitals is Dr. Hiroto Inaba affiliated with?
Dr. Inaba practices at St. Jude Children's Research Hospital in Memphis, Tennessee.
What medical group is Dr. Hiroto Inaba part of?
Dr. Inaba is linked to St. Jude Children's Research Hospital.
Is Dr. Hiroto Inaba board certified?
Yes. Dr. Inaba is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Hiroto Inaba go to medical school?
Dr. Inaba graduated from Other in 1991.
Show 5 more questionsShow fewer questions
Has Dr. Hiroto Inaba received payments from drug or device companies?
CMS Open Payments shows $68,557 in general payments to Dr. Inaba from 7 companies from 2016 to 2025. The largest total came from Amgen Inc.
How long has Dr. Hiroto Inaba been practicing?
Dr. Inaba graduated from medical school in 1991, 35 years ago.
Does Dr. Hiroto Inaba do research?
Dmand AI links 191 publications to Dr. Inaba, published from 2006 to 2025. Dr. Inaba has worked on 4 clinical trials.
Who does Dr. Hiroto Inaba publish with?
Dr. Inaba's most frequent co-authors are Ching-Hon Pui, MD (115 shared papers), Jeffrey E. Rubnitz, MD (63 shared papers) and Seth Evan Karol, MD (32 shared papers).
What insurance does Dr. Hiroto Inaba accept?
Dr. Inaba is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicaid plans come from the most carriers, 4. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card